Sale of 9,132 shares at $3.2364 per share.
Reporting Person Quinn William P. · Officer Title President, CEO and CFO · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Bolt Biotherapeutics, Inc. (BOLT)." Disclosed 2026-09-21. https://desqlong.com/cards/0001193125-26-396890-4 (retrieved 2026-09-26).